Literature DB >> 1590271

Comparison of radiation therapy of classic and epidemic Kaposi's sarcoma.

L F Chang1, S Reddy, H Shidnia.   

Abstract

Between 1963 and 1990, 92 lesions in twenty patients with Kaposi's sarcoma (KS) were treated using radiation therapy (RT). Fifty-nine classic Kaposi's sarcoma (CKS) lesions in 12 patients were treated with 990 cGy in 3 fractions-5,000 cGy in 25 fractions; 39 lesions (66%) showed a complete response (CR), 15 (25%) showed a partial response (PR) with complete symptomatic relief, and 5 lesions (8%) showed no response (NR). Only 6 of 59 lesions (10%) recurred in field with a median recurrence-free duration of 8 months. Thirty-three epidemic Kaposi's sarcoma (EKS) lesions in 8 patients were treated from 1,000 cGy in 5 fractions-3,000 cGy in 10 fractions. Thirty-one EKS lesions (94%) showed CR, and two lesions (6%) showed PR. An extensive review of the literature is also presented in the study here reported.

Entities:  

Mesh:

Year:  1992        PMID: 1590271     DOI: 10.1097/00000421-199206000-00004

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  3 in total

1.  Radiotherapy in the management of Kaposi's sarcoma: comparison of 8 Gy versus 6 Gy.

Authors:  Ferah Yildiz; Mine Genc; Serap Akyurek; Mustafa Cengiz; Enis Ozyar; Ugur Selek; I Lale Atahan
Journal:  J Natl Med Assoc       Date:  2006-07       Impact factor: 1.798

2.  Mucosal Kaposi sarcoma, a Rare Cancer Network study.

Authors:  Juliette Thariat; Youlia Kirova; Terence Sio; Olivier Choussy; Hans Vees; Ulrich Schick; Gilles Poissonnet; Esma Saada; Antoine Thyss; Robert C Miller
Journal:  Rare Tumors       Date:  2012-10-17

3.  Organ-Specific Toxicities Due to Radiation Therapy in Cancer Patients With or Without HIV Infection: A Systematic Review of the Literature.

Authors:  Melody J Xu; Alison Liewen; Luca Valle; Adam C Olson; Nicola M Zetola; Surbhi Grover
Journal:  Front Oncol       Date:  2018-07-30       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.